BioSpace News Archive

LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy, today announces exciting preclinical data demonstrating that its Immunomodulatory Alpha Neutrophil product.

TeselaGen Biotechnology Inc. announces the launch of its Starter Edition, a version of TeselaGen’s software supporting innovative early-stage biotech companies that are ready to scale.

ValGenesis, the market leader in enterprise validation lifecycle management systems (VLMS), today announced the release of ValGenesis Design Manager, a new module within VLMS 4.2 that is ready for computer software assurance (CSA) out of the box.

Progentec Diagnostics announced today the launch of PROACTIVE, a collaborative study with GSK aimed at identifying individuals at risk of developing lupus and guiding them through a virtual diagnostic journey.

Axalbion announced that it will present positive results from a Phase 2 proof-of-concept study with its transient receptor potential melastatin 8 (TRPM8) agonist, AX-8, in patients with refractory or unexplained chronic cough.

OcuSciences today announced a publication in Frontiers in Ophthalmology journal.

Zynex, Inc. announced the Denver Business Journal has ranked Zynex sixth in a list of the largest Denver-area Biotechnology/Bioscience companies, according to the number of full-time employees.

Previse, formerly known as Capsulomics, Inc., announced that the company has closed a $3M seed round and launched its first laboratory-developed test, Esopredict™.

Co-Diagnostics, Inc. announced that the Company CEO will deliver the keynote address at the 4th Annual MarketsandMarkets Infectious Disease Diagnostics and Molecular Diagnostics Conference, held March 23-24, 2023, in London, England, where the Company will also be hosting a booth.

Ally Biotech, a science-based company and provider of leading-edge bioactive cannabinoid delivery solutions, today announced the acquisition of the popular Chill Pill™ brand, an extensive line of soft, easy-to-swallow soft gel caps and all of its assets, from Desert Medical Campus, in an all-cash transaction.